DRAP Suspends Controversial Hormonal Injection Linked to Cancer Risk in Babies: A Bold Move by New C
KARACHI: In a landmark public health decision, the Drug Regulatory Authority of Pakistan (DRAP) has officially suspended the marketing and use of the hormonal drug 17-Hydroxyp...